Pesquisar | ValuTok

Komal Galande adicionou um novo artigo Drinks
2026-03-24 09:28:18

Can RNA Therapeutics Unlock a New Era in Disease Treatment?
Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine This global RNA Therapeutics Market...

0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Coherent MarketMI adicionou um novo artigo Wellness
2026-03-10 10:34:42

RNA Therapeutics Market Growth and Strategic Outlook 2026-2033
The RNA Therapeutics market is witnessing unparalleled growth driven by rapid advancements in gene-editing technologies and an increasing focus on personalized medicine. Industry players are leveraging innovative delivery platforms and expanding clinical pipelines, positioning the market at the forefront of molecular medicine advancements.Market Size and Overview The RNA Therapeutics Market is...

0 Comentários 0 Compartilhamentos 786 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
Komal Galande adicionou um novo artigo Crafts
2026-04-09 08:35:36

Is RNA-Based Therapy the Next Breakthrough in Cancer Treatment?
Executive Summary RNA-Based Cancer Therapeutics Market Size and Share Across Top Segments CAGR Value The global RNA-based cancer therapeutics market size was valued at USD 415.8 million in 2025 and is expected to reach USD 947.1 million by 2033, at a CAGR of 10.80% during the forecast period Market drivers and market restraints covered in this...

0 Comentários 0 Compartilhamentos 486 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!
KUMUD SINGH adicionou um novo artigo Health
2026-03-30 10:22:44

RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%
According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...

0 Comentários 0 Compartilhamentos 466 Visualizações 0 Anterior

Faça o login para curtir, compartilhar e comentar!